Correction: Comparison of in vitro and in vivo toxicity of bupivacaine in musculoskeletal applications - Top-Institutions - MDSpire

Correction: Comparison of in vitro and in vivo toxicity of bupivacaine in musculoskeletal applications

  • By

  • Jasper G. Steverink

  • Susanna Piluso

  • Jos Malda

  • Jorrit-Jan Verlaan

  • May 26, 2026

  • 0 min

Share

Top Institutions in Orthopedic Medicine

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Anesthesiology
    • Orthopedics

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Anesthesiology
    • Pain Medicine

  • #3

    Second Xiangya Hospital of Central South University
    Second Xiangya Hospital of Central South University

    Changsha, Hunan

    Key Differentiators

    • Anesthesiology

  • #4

    The Ottawa Hospital
    The Ottawa Hospital

    Ottawa, Ontario

    Key Differentiators

    • Anesthesiology

  • #5

    Shanghai Tenth People’s Hospital
    Shanghai Tenth People’s Hospital

    Shanghai, Shanghai

    Key Differentiators

    • Anesthesiology

Original Source(s)

Correction: Comparison of in vitro and in vivo toxicity of bupivacaine in musculoskeletal applications

  • by Jasper G. Steverink, Susanna Piluso, Jos Malda, Jorrit-Jan Verlaan

  • May 26, 2026

Related Content

Stem cell therapies for biological repair in osteonecrosis: advances, challenges, and clinical insights

Development and internal validation of a nomogram for predicting short-term functional improvement after pharmacological treatment in severe symptomatic lumbar disk herniation

Cadonilimab in the treatment of advanced metastatic soft tissue clear cell sarcoma achieved complete remission: a case report